메뉴 건너뛰기




Volumn 129, Issue 3, 2012, Pages 353-359

Anticancer treatment and thrombosis

Author keywords

cancer; chemotherapy; hormonal therapy; prophylaxis; venous thromboembolism

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DALTEPARIN; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ENOXAPARIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; LENALIDOMIDE; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; OXALIPLATIN; PRINOMASTAT; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TAMOXIFEN; THALIDOMIDE; WARFARIN;

EID: 84857792538     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.025     Document Type: Review
Times cited : (42)

References (89)
  • 1
    • 36049000503 scopus 로고    scopus 로고
    • Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
    • DOI 10.1002/cncr.23062
    • A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2007 2339 2346 (Pubitemid 350100757)
    • (2007) Cancer , vol.110 , Issue.10 , pp. 2339-2346
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Kuderer, N.M.4    Lyman, G.H.5
  • 2
    • 61449137068 scopus 로고    scopus 로고
    • Overview of the postulated mechanisms linking cancer and thrombosis
    • H. ten Cate, and A. Falanga Overview of the postulated mechanisms linking cancer and thrombosis Pathophysiol Haemost Thromb 36 2008 122 130
    • (2008) Pathophysiol Haemost Thromb , vol.36 , pp. 122-130
    • Ten Cate, H.1    Falanga, A.2
  • 3
    • 13244265094 scopus 로고    scopus 로고
    • Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression
    • A. Falanga, M. Marchetti, A. Vignoli, and D. Balducci Clotting mechanisms and cancer: implications in thrombus formation and tumor progression Clin Adv Hematol Oncol 1 2003 673 678
    • (2003) Clin Adv Hematol Oncol , vol.1 , pp. 673-678
    • Falanga, A.1    Marchetti, M.2    Vignoli, A.3    Balducci, D.4
  • 4
    • 0038718518 scopus 로고    scopus 로고
    • Venous thromboembolism and cancer: Risks and outcomes
    • A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
    • (2003) Circulation , vol.107
    • Lee, A.Y.1    Levine, M.N.2
  • 9
    • 40849111771 scopus 로고    scopus 로고
    • Clinical characteristics and management of cancer-associated acute venous thromboembolism: Findings from the MASTER Registry
    • DOI 10.3324/haematol.11458
    • D. Imberti, G. Agnelli, W. Ageno, M. Moia, G. Palareti, and R. Pistelli Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry Haematologica 93 2008 273 278 (Pubitemid 351397716)
    • (2008) Haematologica , vol.93 , Issue.2 , pp. 273-278
    • Imberti, D.1    Agnelli, G.2    Ageno, W.3    Moia, M.4    Palareti, G.5    Pistelli, R.6    Rossi, R.7    Verso, M.8
  • 14
    • 0036213529 scopus 로고    scopus 로고
    • Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics
    • S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579 (Pubitemid 34302943)
    • (2002) Thrombosis and Haemostasis , vol.87 , Issue.4 , pp. 575-579
    • Sallah, S.1    Wan, J.Y.2    Nguyen, N.P.3
  • 15
    • 30944433554 scopus 로고    scopus 로고
    • Incidence of venous thromboembolism in patients hospitalized with cancer
    • DOI 10.1016/j.amjmed.2005.06.058, PII S0002934305005644
    • P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68 (Pubitemid 43117468)
    • (2006) American Journal of Medicine , vol.119 , Issue.1 , pp. 60-68
    • Stein, P.D.1    Beemath, A.2    Meyers, F.A.3    Skaf, E.4    Sanchez, J.5    Olson, R.E.6
  • 17
    • 0036278814 scopus 로고    scopus 로고
    • Variation in relative risk of venous thromboembolism in different cancers
    • P.A. Thodiyil, and A.K. Kakkar Variation in relative risk of venous thromboembolism in different cancers Thromb Haemost 87 2002 1076 1077 (Pubitemid 34624894)
    • (2002) Thrombosis and Haemostasis , vol.87 , Issue.6 , pp. 1076-1077
    • Thodiyil, P.A.1    Kakkar, A.K.2
  • 18
    • 33644597912 scopus 로고    scopus 로고
    • Incidence of venous thromboembolism and its effect on survival among patients with common cancers
    • H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
    • (2006) Arch Intern Med , vol.166 , pp. 458-464
    • Chew, H.K.1    Wun, T.2    Harvey, D.3    Zhou, H.4    White, R.H.5
  • 23
    • 29144486069 scopus 로고    scopus 로고
    • Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
    • DOI 10.1002/cncr.21496
    • A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 2005 2822 2829 (Pubitemid 41798294)
    • (2005) Cancer , vol.104 , Issue.12 , pp. 2822-2829
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Lyman, G.H.4
  • 24
    • 33645749796 scopus 로고    scopus 로고
    • The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma
    • M. Mandala, A. Falanga, M. Cremonesi, M. Zaccanelli, I. Floriani, and M.G. Vigano The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma Thromb Haemost 95 2006 752 754
    • (2006) Thromb Haemost , vol.95 , pp. 752-754
    • Mandala, M.1    Falanga, A.2    Cremonesi, M.3    Zaccanelli, M.4    Floriani, I.5    Vigano, M.G.6
  • 25
    • 34248374711 scopus 로고    scopus 로고
    • The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma
    • DOI 10.1002/cncr.22626
    • E.D. Tetzlaff, A.M. Correa, J. Baker, J. Ensor, and J.A. Ajani The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma Cancer 109 2007 1989 1995 (Pubitemid 46744192)
    • (2007) Cancer , vol.109 , Issue.10 , pp. 1989-1995
    • Tetzlaff, E.D.1    Correa, A.M.2    Baker, J.3    Ensor, J.4    Ajani, J.A.5
  • 27
    • 0141973788 scopus 로고    scopus 로고
    • Venous thromboembolism associated with long-term use of central venous catheters in cancer patients
    • DOI 10.1200/JCO.2003.08.008
    • M. Verso, and G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3665 3675 (Pubitemid 46594061)
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.19 , pp. 3665-3675
    • Verso, M.1    Agnelli, G.2
  • 28
    • 1842556758 scopus 로고    scopus 로고
    • Thrombotic Complications of Central Venous Catheters in Cancer Patients
    • DOI 10.1634/theoncologist.9-2-207
    • D.J. Kuter Thrombotic complications of central venous catheters in cancer patients Oncologist 9 2004 207 216 (Pubitemid 38452120)
    • (2004) Oncologist , vol.9 , Issue.2 , pp. 207-216
    • Kuter, D.J.1
  • 34
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0656
    • W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 381S 453S (Pubitemid 351894916)
    • (2008) Chest , vol.133 , Issue.SUPPL. 6
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3    Heit, J.A.4    Samama, C.M.5    Lassen, M.R.6    Colwell, C.W.7
  • 35
    • 38349068632 scopus 로고    scopus 로고
    • Clinical outcome of patients with upper-extremity deep vein thrombosis: Results from the RIETE Registry
    • F.J. Munoz, P. Mismetti, R. Poggio, R. Valle, M. Barron, and M. Guil Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry Chest 133 2008 143 148
    • (2008) Chest , vol.133 , pp. 143-148
    • Munoz, F.J.1    Mismetti, P.2    Poggio, R.3    Valle, R.4    Barron, M.5    Guil, M.6
  • 36
    • 35648954192 scopus 로고    scopus 로고
    • Adjuvant therapy and thrombosis: How to avoid the problem?
    • M.N. Levine Adjuvant therapy and thrombosis: how to avoid the problem? Breast 16 Suppl. 2 2007 S169 S174
    • (2007) Breast , vol.16 , Issue.SUPPL. 2
    • Levine, M.N.1
  • 38
    • 34247568441 scopus 로고    scopus 로고
    • Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [10]
    • DOI 10.1111/j.1538-7836.2007.02374.x
    • A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634 (Pubitemid 46680709)
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , Issue.3 , pp. 632-634
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Kuderer, N.M.4    Lyman, G.H.5
  • 39
    • 20444433198 scopus 로고    scopus 로고
    • In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: Modulation by lower-dose chemotherapy
    • DOI 10.1158/0008-5472.CAN-04-3156
    • L. Ma, G. Francia, A. Viloria-Petit, D.J. Hicklin, J. du Manoir, and J. Rak In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy Cancer Res 65 2005 5365 5373 (Pubitemid 40827350)
    • (2005) Cancer Research , vol.65 , Issue.12 , pp. 5365-5373
    • Ma, L.1    Francia, G.2    Viloria-Petit, A.3    Hicklin, D.J.4    Du Manoir, J.5    Rak, J.6    Kerbel, R.S.7
  • 40
    • 79953304684 scopus 로고    scopus 로고
    • The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models
    • L.L. Swystun, S. Mukherjee, M. Levine, and P.C. Liaw The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models J Thromb Haemost 9 2011 767 775
    • (2011) J Thromb Haemost , vol.9 , pp. 767-775
    • Swystun, L.L.1    Mukherjee, S.2    Levine, M.3    Liaw, P.C.4
  • 41
    • 63049125016 scopus 로고    scopus 로고
    • Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
    • L.L. Swystun, L.Y. Shin, S. Beaudin, and P.C. Liaw Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes J Thromb Haemost 7 2009 619 626
    • (2009) J Thromb Haemost , vol.7 , pp. 619-626
    • Swystun, L.L.1    Shin, L.Y.2    Beaudin, S.3    Liaw, P.C.4
  • 42
    • 36348999748 scopus 로고    scopus 로고
    • Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity
    • DOI 10.1111/j.1538-7836.2007.02788.x
    • D. Lechner, M. Kollars, A. Gleiss, P.A. Kyrle, and A. Weltermann Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity J Thromb Haemost 5 2007 2445 2452 (Pubitemid 350154355)
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , Issue.12 , pp. 2445-2452
    • Lechner, D.1    Kollars, M.2    Gleiss, A.3    Kyrle, P.A.4    Weltermann, A.5
  • 43
    • 80055116732 scopus 로고    scopus 로고
    • Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity
    • [Electronic publication ahead of print]
    • J.C. Boles, J.C. Williams, R.M. Hollingsworth, J.G. Wang, S.L. Glover, and A.P. Owens III Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity Thromb Res 2011 July 13 [Electronic publication ahead of print]
    • (2011) Thromb Res
    • Boles, J.C.1    Williams, J.C.2    Hollingsworth, R.M.3    Wang, J.G.4    Glover, S.L.5    Owens Iii, A.P.6
  • 44
    • 78649752778 scopus 로고    scopus 로고
    • Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release
    • Y. Fu, J. Zhou, H. Li, F. Cao, Y. Su, and S. Fan Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release Thromb Haemost 104 2010 1235 1241
    • (2010) Thromb Haemost , vol.104 , pp. 1235-1241
    • Fu, Y.1    Zhou, J.2    Li, H.3    Cao, F.4    Su, Y.5    Fan, S.6
  • 45
    • 41149154862 scopus 로고    scopus 로고
    • Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: A study of the Arbeitsgemeinschaft Internistische Onkologie
    • S.E. Al-Batran, J.T. Hartmann, S. Probst, H. Schmalenberg, S. Hollerbach, and R. Hofheinz Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 2008 1435 1442
    • (2008) J Clin Oncol , vol.26 , pp. 1435-1442
    • Al-Batran, S.E.1    Hartmann, J.T.2    Probst, S.3    Schmalenberg, H.4    Hollerbach, S.5    Hofheinz, R.6
  • 46
    • 80052751246 scopus 로고    scopus 로고
    • High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: A large retrospective analysis
    • R.A. Moore, N. Adel, E. Riedel, M. Bhutani, D.R. Feldman, and N.E. Tabbara High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis J Clin Oncol 29 2011 3466 3473
    • (2011) J Clin Oncol , vol.29 , pp. 3466-3473
    • Moore, R.A.1    Adel, N.2    Riedel, E.3    Bhutani, M.4    Feldman, D.R.5    Tabbara, N.E.6
  • 47
  • 50
    • 3242773754 scopus 로고    scopus 로고
    • The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: A systematic review
    • DOI 10.1002/cncr.20347
    • S.R. Deitcher, and M.P. Gomes The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review Cancer 101 2004 439 449 (Pubitemid 38970595)
    • (2004) Cancer , vol.101 , Issue.3 , pp. 439-449
    • Deitcher, S.R.1    Gomes, M.P.V.2
  • 52
    • 84857787311 scopus 로고    scopus 로고
    • Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways
    • [Electronic publication ahead of print]
    • V.P. Shah, H.A. Chegini, S.R. Vishneski, R.V. Weatherman, P.F. Blackmore, and Y. Dobrydneva Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways Thromb Res 2011 Aug 27 [Electronic publication ahead of print]
    • (2011) Thromb Res
    • Shah, V.P.1    Chegini, H.A.2    Vishneski, S.R.3    Weatherman, R.V.4    Blackmore, P.F.5    Dobrydneva, Y.6
  • 53
    • 0029783365 scopus 로고    scopus 로고
    • Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer
    • K.I. Pritchard, A.H. Paterson, N.A. Paul, B. Zee, S. Fine, and J. Pater Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group J Clin Oncol 14 1996 2731 2737 (Pubitemid 26329659)
    • (1996) Journal of Clinical Oncology , vol.14 , Issue.10 , pp. 2731-2737
    • Pritchard, K.I.1    Paterson, A.H.G.2    Paul, N.A.3    Zee, B.4    Fine, S.5    Pater, J.6
  • 56
    • 0037157603 scopus 로고    scopus 로고
    • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial
    • DOI 10.1016/S0140-6736(02)09088-8
    • M. Baum, A.U. Budzar, J. Cuzick, J. Forbes, J.H. Houghton, and J.G. Klijn Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139 (Pubitemid 34694019)
    • (2002) Lancet , vol.359 , Issue.9324 , pp. 2131-2139
    • Baum, M.1    Buzdar, A.U.2    Cuzick, J.3    Forbes, J.4    Houghton, J.5    Klijn, J.G.M.6    Sahmoud, T.7
  • 57
    • 77952171390 scopus 로고    scopus 로고
    • Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: A prospective trial
    • M. Mandala, S. Barni, M. Prins, R. Labianca, C. Tondini, and L. Russo Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial Ann Oncol 21 2010 871 876
    • (2010) Ann Oncol , vol.21 , pp. 871-876
    • Mandala, M.1    Barni, S.2    Prins, M.3    Labianca, R.4    Tondini, C.5    Russo, L.6
  • 58
    • 0028217482 scopus 로고
    • Phase i and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma
    • J.L. Grem, N. McAtee, R.F. Murphy, J.M. Hamilton, F. Balis, and S. Steinberg Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma J Clin Oncol 12 1994 560 568
    • (1994) J Clin Oncol , vol.12 , pp. 560-568
    • Grem, J.L.1    McAtee, N.2    Murphy, R.F.3    Hamilton, J.M.4    Balis, F.5    Steinberg, S.6
  • 60
    • 55549105814 scopus 로고    scopus 로고
    • Hemostatic complications of angiogenesis inhibitors in cancer patients
    • F. Elice, J. Jacoub, F.R. Rickles, A. Falanga, and F. Rodeghiero Hemostatic complications of angiogenesis inhibitors in cancer patients Am J Hematol 83 2008 862 870
    • (2008) Am J Hematol , vol.83 , pp. 862-870
    • Elice, F.1    Jacoub, J.2    Rickles, F.R.3    Falanga, A.4    Rodeghiero, F.5
  • 61
    • 0142029001 scopus 로고    scopus 로고
    • Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy
    • C.E. Behrendt, and R.B. Ruiz Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy Thromb Haemost 90 2003 734 737 (Pubitemid 37287643)
    • (2003) Thrombosis and Haemostasis , vol.90 , Issue.4 , pp. 734-737
    • Behrendt, C.E.1    Ruiz, R.B.2
  • 64
    • 33745291997 scopus 로고    scopus 로고
    • Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations
    • DOI 10.1160/TH06-02-0080
    • M.A. Hussein Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations Thromb Haemost 95 2006 924 930 (Pubitemid 43933748)
    • (2006) Thrombosis and Haemostasis , vol.95 , Issue.6 , pp. 924-930
    • Hussein, M.A.1
  • 65
    • 0037103292 scopus 로고    scopus 로고
    • Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: Implications for therapy
    • DOI 10.1182/blood-2002-01-0335
    • M. Zangari, E. Siegel, B. Barlogie, E. Anaissie, F. Saghafifar, and A. Fassas Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy Blood 100 2002 1168 1171 (Pubitemid 34864267)
    • (2002) Blood , vol.100 , Issue.4 , pp. 1168-1171
    • Zangari, M.1    Siegel, E.2    Barlogie, B.3    Anaissie, E.4    Saghafifar, F.5    Fassas, A.6    Morris, C.7    Fink, L.8    Tricot, G.9
  • 67
    • 0141452131 scopus 로고    scopus 로고
    • Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
    • DOI 10.1002/cncr.11700
    • T. Wun, L. Law, D. Harvey, B. Sieracki, S.A. Scudder, and J.K. Ryu Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin Cancer 98 2003 1514 1520 (Pubitemid 37151508)
    • (2003) Cancer , vol.98 , Issue.7 , pp. 1514-1520
    • Wun, T.1    Law, L.2    Harvey, D.3    Sieracki, B.4    Scudder, S.A.5    Ryu, J.K.6
  • 69
    • 43449115194 scopus 로고    scopus 로고
    • Development and validation of a predictive model for chemotherapy- associated thrombosis
    • A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
    • (2008) Blood , vol.111 , pp. 4902-4907
    • Khorana, A.A.1    Kuderer, N.M.2    Culakova, E.3    Lyman, G.H.4    Francis, C.W.5
  • 70
    • 84857783741 scopus 로고    scopus 로고
    • A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening in A Prospective Study
    • (ASH Annual Meeting Abstracts)
    • A.A. Khorana, K. Herman, D. Rubens, and C.W. Francis A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening In A Prospective Study Blood Cells 116 2010 3173 (ASH Annual Meeting Abstracts).
    • (2010) Blood Cells , vol.116 , pp. 3173
    • Khorana, A.A.1    Herman, K.2    Rubens, D.3    Francis, C.W.4
  • 71
    • 53449093751 scopus 로고    scopus 로고
    • High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS)
    • C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, and S. Koder High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 2008 2703 2708
    • (2008) Blood , vol.112 , pp. 2703-2708
    • Ay, C.1    Simanek, R.2    Vormittag, R.3    Dunkler, D.4    Alguel, G.5    Koder, S.6
  • 72
    • 70249119693 scopus 로고    scopus 로고
    • D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: Results from the Vienna Cancer and Thrombosis Study
    • C. Ay, R. Vormittag, D. Dunkler, R. Simanek, A.L. Chiriac, and J. Drach D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 2009 4124 4129
    • (2009) J Clin Oncol , vol.27 , pp. 4124-4129
    • Ay, C.1    Vormittag, R.2    Dunkler, D.3    Simanek, R.4    Chiriac, A.L.5    Drach, J.6
  • 74
    • 0033850037 scopus 로고    scopus 로고
    • Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis
    • B.A. Hutten, M.H. Prins, M. Gent, J. Ginsberg, J.G. Tijssen, and H.R. Buller Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis J Clin Oncol 18 2000 3078 3083
    • (2000) J Clin Oncol , vol.18 , pp. 3078-3083
    • Hutten, B.A.1    Prins, M.H.2    Gent, M.3    Ginsberg, J.4    Tijssen, J.G.5    Buller, H.R.6
  • 75
    • 0030751133 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group
    • Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group Br J Surg 84 1997 1099 1103
    • (1997) Br J Surg , vol.84 , pp. 1099-1103
  • 77
    • 70350714641 scopus 로고    scopus 로고
    • Venous thromboembolism prophylaxis and treatment in cancer: A consensus statement of major guidelines panels and call to action
    • A.A. Khorana, M.B. Streiff, D. Farge, M. Mandala, P. Debourdeau, and F. Cajfinger Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action J Clin Oncol 27 2009 4919 4926
    • (2009) J Clin Oncol , vol.27 , pp. 4919-4926
    • Khorana, A.A.1    Streiff, M.B.2    Farge, D.3    Mandala, M.4    Debourdeau, P.5    Cajfinger, F.6
  • 79
    • 68649111822 scopus 로고    scopus 로고
    • A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial
    • (abstract)
    • H. Riess, U. Pelzer, G. Deutschinoff, B. Opitz, M. Stauch, and P. Reitzig A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial J Clin Oncol 27 2009 LBA4506 (abstract).
    • (2009) J Clin Oncol , vol.27 , pp. 4506
    • Riess, H.1    Pelzer, U.2    Deutschinoff, G.3    Opitz, B.4    Stauch, M.5    Reitzig, P.6
  • 80
    • 58149377600 scopus 로고    scopus 로고
    • Rationale and design of PROSPECT-CONKO 004: A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
    • H. Riess, U. Pelzer, A. Hilbig, J. Stieler, B. Opitz, and T. Scholten Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy) BMC Cancer 8 2008 361
    • (2008) BMC Cancer , vol.8 , pp. 361
    • Riess, H.1    Pelzer, U.2    Hilbig, A.3    Stieler, J.4    Opitz, B.5    Scholten, T.6
  • 81
    • 79955092671 scopus 로고    scopus 로고
    • Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): A multicentre, randomised phase IIB trial (the UK FRAGEM study)
    • A. Maraveyas, J. Waters, R. Roy, D. Propper, D. Fyfe, and F. Lofts Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study) Eur J Cancer Suppl 7 2009 362
    • (2009) Eur J Cancer Suppl , vol.7 , pp. 362
    • Maraveyas, A.1    Waters, J.2    Roy, R.3    Propper, D.4    Fyfe, D.5    Lofts, F.6
  • 82
    • 33749320687 scopus 로고    scopus 로고
    • Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer - Results of the TOPIC Studies
    • (abstract)
    • S.K. Haas, A.K. Kakkar, B. Kemkes-Matthes, M. Freund, U. Gatzemeier, and L. Heilmann Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer - Results of the TOPIC Studies J Thromb Haemost 3 2005 OR059 (abstract).
    • (2005) J Thromb Haemost , vol.3 , pp. 059
    • Haas, S.K.1    Kakkar, A.K.2    Kemkes-Matthes, B.3    Freund, M.4    Gatzemeier, U.5    Heilmann, L.6
  • 83
    • 77956471946 scopus 로고    scopus 로고
    • PRODIGE: A randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
    • J.R. Perry, J.A. Julian, N.J. Laperriere, W. Geerts, G. Agnelli, and L.R. Rogers PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma J Thromb Haemost 8 2010 1959 1965
    • (2010) J Thromb Haemost , vol.8 , pp. 1959-1965
    • Perry, J.R.1    Julian, J.A.2    Laperriere, N.J.3    Geerts, W.4    Agnelli, G.5    Rogers, L.R.6
  • 84
    • 70349398317 scopus 로고    scopus 로고
    • Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study
    • G. Agnelli, G. Gussoni, C. Bianchini, M. Verso, M. Mandala, and L. Cavanna Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Lancet Oncol 10 2009 943 949
    • (2009) Lancet Oncol , vol.10 , pp. 943-949
    • Agnelli, G.1    Gussoni, G.2    Bianchini, C.3    Verso, M.4    Mandala, M.5    Cavanna, L.6
  • 85
    • 33745909893 scopus 로고    scopus 로고
    • International Consensus Statement (guidelines according to scientific evidence)
    • Prevention and treatment of venous thromboembolism
    • Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence) Int Angiol 25 2006 101 161
    • (2006) Int Angiol , vol.25 , pp. 101-161
  • 86
    • 77955507375 scopus 로고    scopus 로고
    • The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients
    • M.B. Streiff The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients Thromb Res 125 Suppl. 2 2010 S128 S133
    • (2010) Thromb Res , vol.125 , Issue.SUPPL. 2
    • Streiff, M.B.1
  • 87
    • 77953580551 scopus 로고    scopus 로고
    • 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
    • D. Farge, L. Bosquet, D. Kassab-Chahmi, P. Mismetti, I. Elalamy, and G. Meyer 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group Crit Rev Oncol Hematol 73 2010 31 46
    • (2010) Crit Rev Oncol Hematol , vol.73 , pp. 31-46
    • Farge, D.1    Bosquet, L.2    Kassab-Chahmi, D.3    Mismetti, P.4    Elalamy, I.5    Meyer, G.6
  • 88
    • 77954325044 scopus 로고    scopus 로고
    • Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management
    • M. Mandala, A. Falanga, and F. Roila Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management Ann Oncol 21 Suppl. 5 2010 v274 v276
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5
    • Mandala, M.1    Falanga, A.2    Roila, F.3
  • 89
    • 77955496152 scopus 로고    scopus 로고
    • Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines
    • G.H. Lyman, and N.M. Kuderer Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines Thromb Res 125 Suppl. 2 2010 S120 S127
    • (2010) Thromb Res , vol.125 , Issue.SUPPL. 2
    • Lyman, G.H.1    Kuderer, N.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.